The Government provided additional funding to Pharmac in June 2024 to fund new medicines and widen access to medicines that are already funded. Since receiving the additional funding, Pharmac has ...
Completed strategic review to focus on oncology and liver diseases with the acquisition of global rights to GB3226 (formerly BRM-1420), a dual ...
When combined with trastuzumab and chemotherapy, treatment with pembrolizumab was associated with a statistically significant improvement in PFS and OS compared with placebo.
On March 19, the Food and Drug Administration granted traditional approval to pembrolizumab, or Keytruda, marketed by Merck (MRK), with ...
During a live event, Thach-Giao Truong, MD, moderated a discussion on treating a 78-year-old patient with metastatic melanoma ...
MedPage Today on MSN23h
End of the Road for Immune Checkpoint Inhibitors in Prostate Cancer?Adding an immune checkpoint inhibitor (ICI) to chemotherapy for advanced prostate cancer failed to improve survival as ...
The researchers called for further study to understand the mechanism of the relationship between obesity and ICI outcomes.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback